Stay updated on Nivolumab Ruxolitinib in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ruxolitinib in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ruxolitinib in Hodgkin Lymphoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6, indicating a maintenance update to the listing.
    Difference
    0.1%
    Check dated 2026-08-30T21:39:50.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The revision tag on the page has been updated from v3.6.4 to v3.6.5. This indicates a newer page version.
    Difference
    0.0%
    Check dated 2026-08-09T09:14:47.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Footer revision updated from v3.6.3 to v3.6.4, indicating a newer build of the page.
    Difference
    0.0%
    Check dated 2026-07-25T17:57:31.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, replacing the previous v3.6.2, signaling a new page revision was published. This appears to be a minor maintenance update and does not change the study details.
    Difference
    0.0%
    Check dated 2026-07-04T09:23:14.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.2 on the page, indicating a minor update to the page. It does not affect the study details or data shown.
    Difference
    0.0%
    Check dated 2026-06-27T05:54:57.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    Updated the page to reflect revision v3.6.0 (2026-06-12) by adding new study contact details for Veronika Bachanova (MD) with phone and email, removing older contacts such as Erin Zielinski, and introducing new help/navigation sections (Check who can join, How to Read a Study Record, Common Questions, How to Join a Study).
    Difference
    0.9%
    Check dated 2026-06-12T23:55:13.000Z thumbnail image

Stay in the know with updates to Nivolumab Ruxolitinib in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ruxolitinib in Hodgkin Lymphoma Clinical Trial page.